drugset / Trial / NCT02172469
Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the bronchodilator efficacy and safety of tiotropium inhalation capsules (18 µg once daily) and Atrovent® MDI (2 puffs of 20µg q.i.d.) among Filipino patients with COPD
Timeline
- Start
- 2001-05
- Primary completion
- 2002-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ipratropium | Small molecule | 20 ug | Inhaled |
| Subject | Tiotropium | Other / unclassified | 18 ug | Inhaled |